Wikipedia
Evogliptin
Evogliptin (trade name Suganon, previously identified as DA-1229, Dong-A ST) is an antidiabetic drug in the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. It was developed by the South Korean pharmaceutical company Dong-A.